FLGT FY 2016 Earnings — Fulgent Genetics, Inc. Revenue & Financial Results | Market Cap Arena

FLGTFulgent Genetics, Inc.

$449M

FY 2016 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$18M+90.9% YoY

Gross Profit

$12M63.2% margin

Operating Income

$919,0005.0% margin

Net Income

-$5M-29.3% margin

EPS (Diluted)

$-0.30

Cash Flow

Operating Cash Flow

$4M

Free Cash Flow

$617,000

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$58M

Total Liabilities

$4M

Stockholders' Equity

$54M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$10M	+90.9%
Gross Profit	$12M	$5M	+156.4%
Operating Income	$919,000	-$5M	+118.3%
Net Income	-$5M	-$8M	+35.7%